According to Harvard Bioscience's latest financial reports the company's current earnings (TTM) are -NZ$15.25 M. In 2023 the company made an earning of -NZ$4.14 M an increase over its 2022 earnings that were of -NZ$14.84 M.The earnings displayed on this page is the company's Pretax Income.